$3.00
+1.66 (+123.88%)
Open$1.90
Previous Close$1.34
Day High$3.97
Day Low$1.63
52W High$3.97
52W Low$0.30
Volume—
Avg Volume80.44M
Market Cap7.65M
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.35M | 2.04M | 1.76M |
| Net Income | -57,003,400 | -44,414,388 | -56,960 |
| Profit Margin | -2,421.8% | -2,300.7% | -3.2% |
| EBITDA | -51,515,436 | -42,368,335 | -70,729 |
| Free Cash Flow | — | — | -37,098 |
| Rev Growth | +15.5% | +15.5% | +11.5% |
| Debt/Equity | 0.37 | 0.37 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |